ArticleThoracic cancer2025

The Impact of Immune-Related Adverse Event Severity on Prognosis in Elderly Patients With Nonsmall-Cell Lung Cancer in First-Line Immune Checkpoint Inhibitor Treatment.

Ippei Miyamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.